SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ZURA

Zura Bio Ltd.
NASDAQHealth Care

Latest close: 3.90 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 18, 2026Notice of sale · Form 144SOMEIT SIDHU · Director · $287.7KOpen the filing ↗
  2. Aug 17, 2026Notice of sale · Form 144SOMEIT SIDHU · Director · $151.3KOpen the filing ↗
  3. Aug 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record41722 flagged findings
Reported transactions (Form 4)74since Feb 10, 2023 · and 36 other holdings
Corporate events (8-K)30since May 3, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as JATT.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…in addition to the terms described above and shall remain in effect on a country-by-country basis until the expiration of the…”
    +1 more passage from the same document
    • “…and December 31, 2025, there was an aggregate 29,295,396 and 27,495,396 pre-funded warrants outstanding, respectively, each with…”
  • 2026-03-19share offering or dilution eventrecentOpen filing ↗
    “…JATT completed its IPO. On March 20, 2023 (the “Closing Date”), we consummated a series of transactions contemplated by that…”
    +1 more passage from the same document
    • “…of operations for the year-ended December 31, 2025. ​ 6. Shareholders’ Equity On March 16, 2023, in connection with the closing…”
  • 2026-03-19listing compliance noticerecentOpen filing ↗
    “…of a delisting, we can provide no assurance that any action taken to restore compliance with listing requirements would allow our…”
    +1 more passage from the same document
    • “…continued listing requirements. In the event of a delisting, we can provide no assurance that any action taken to restore compliance…”
  • 2026-03-19Department of Justice inquiryrecentOpen filing ↗
    “…and injunctions against our processing or transferring of personal data necessary to operate our business. Additionally, companies…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 417)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Aug 17, 268-K ↗Current report · Communication to the market
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Aug 11, 268-K ↗Current report · Results · Communication to the market
  • Aug 11, 2610-Q ↗Quarterly report
  • Jul 1, 268-K ↗Current report · Communication to the market
  • Jun 22, 26Form 3 ↗Insider transaction
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jun 18, 268-K ↗Current report · A senior executive left or was appointed
  • May 22, 26DEFA14A ↗Shareholder meeting and votes
  • May 22, 268-K ↗Current report · A senior executive left or was appointed
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Venrock Healthcare Capital Partners III, L.P. · 9.9% · event on Mar 31, 26 · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Great Point Partners, LLC · 4.4% · event on Mar 31, 26 · amendment
  • May 12, 26SCHEDULE 13G/A ↗Passive stake · Suvretta Capital Management, LLC · 9.9% · event on Mar 31, 26 · amendment
  • May 7, 268-K ↗Current report · Results · Communication to the market
  • May 7, 2610-Q ↗Quarterly report
  • May 6, 26SCHEDULE 13G/A ↗Passive stake · JPMORGAN CHASE & CO · 4.7% · event on Apr 30, 26 · amendment

417 filings on record, the oldest from May 5, 21.

Listing the 25 most recent filings of the 417 on record.

8-Ks, explained

Stress1Structure29Governance22
  • Governance3 senior executive changes2026show all 3hide
    • Jun 18, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 22, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Apr 23, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Feb 26, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Feb 23, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 26, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 2, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2025show all 4hide
    • Dec 17, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Oct 10, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 30, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jul 1, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 17, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Oct 18, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 21, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 12, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jul 25, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 2, 24GovernanceA senior executive left or was appointed8-K/A 5.02 ↗

8 older filings not shown · The record reaches back to Jul 19, 21.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 8, 22StressPast accounts declared unreliable and being restated8-K 4.02 ↗

The full record holds 1 stress filing.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • AI Biotechnology LLC18.2%Feb 26, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Athanor Capital15.7%Jan 23, 26SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Athanor Capital15.7%Dec 29, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Venrock Healthcare Capital Partners III, L.P.9.9%Mar 31, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Suvretta Capital Management, LLC9.9%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • RA Capital Management, L.P.4.9%Dec 31, 24SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • JPMORGAN CHASE & CO4.7%Apr 30, 26SCHEDULE 13G/A ↗1 earlier filing
show 2 more holdershide
  • Great Point Partners, LLC4.4%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Deep Track Capital, LP0.4%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 18, SOMEIT SIDHU filed notice of intent to sell up to $288K. That is about 0.05% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+3 more recent notices

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Feb 26, 26Buy$12.5MAI Biotechnology LLC↗
  • Nov 25, 24Sell$2.7MParvinder Thiara↗
  • Sep 11, 24Sell$10.3MParvinder Thiara↗
  • Sep 4, 24Sell$200KSomeit Sidhu↗
  • May 17, 24Buy$496Kvan Amstel Arnout Ploos↗
  • Apr 22, 24Buy$3.7MSomeit Sidhu↗
  • Apr 22, 24Buy$500KAmit Munshi↗
  • Apr 22, 24Buy$10KKiran NistalaExecutive Vice President↗
  • Apr 22, 24Buy$25KMichael HowellSee Remarks↗
  • Dec 12, 23Sell$8.0MParvinder Thiara↗
  • Jun 5, 23Buy$500KAmit Munshi↗
Stock compensation, tax and giftsshow the 23 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 16, 24Compensationamount n/aKim DavisChief Legal Officer↗
  • Sep 4, 24Otheramount n/aSomeit Sidhu↗
  • Aug 24, 24Compensationamount n/aSomeit Sidhu↗
  • Aug 24, 24Compensationamount n/aSomeit Sidhu↗
  • Aug 23, 24Compensationamount n/aVerender S. BadialChief Financial Officer↗
  • May 18, 24Tax$60KMichael HowellSee Remarks↗
  • Apr 22, 24Compensation$25KMichael HowellSee Remarks↗
  • Apr 22, 24Compensation$500KAmit Munshi↗
  • Apr 22, 24Compensation$3.7MSomeit Sidhu↗
  • Apr 22, 24Compensation$10KKiran NistalaSee Remarks↗
  • Nov 21, 23Otheramount n/aSomeit Sidhu↗
  • Oct 1, 23Compensationamount n/aKim DavisChief Legal Officer↗
  • Sep 28, 23Otheramount n/aVerender S. BadialChief Financial Officer↗
  • Sep 28, 23Otheramount n/aSomeit Sidhu↗
  • Sep 22, 23Otheramount n/aVerender S. BadialChief Financial Officer↗
  • Sep 22, 23Otheramount n/aSomeit Sidhu↗
  • May 18, 23Compensationamount n/aChristopher CabellCMO & Head of R&D↗
  • May 18, 23Compensationamount n/aKim DavisChief Legal Officer↗
  • May 18, 23Compensationamount n/aMichael HowellSee Remarks↗
  • Mar 20, 23Otheramount n/aSomeit SidhuChief Executive Officer↗
  • Mar 20, 23Other$5.7MOwl Creek Asset Management, L.P.↗
  • Feb 10, 23Otheramount n/aSomeit SidhuChief Executive Officer↗
  • Feb 10, 23Otheramount n/aJATT Ventures, L.P.↗

The full record holds 34 transactions and goes back to Jan 9, 23.

Its sector and its market

Zura Bio Ltd. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Zura Bio Ltd., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Zura Bio Ltd. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
417 documents on file, from May 5, 2021 to Aug 18, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.